Tetracycline (Achromycin)

Subscribe to Selected New Research on Tetracycline

4051 relevant articles (332 outcomes, 402 trials/studies) found for this Drug

Description: A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.

Also Known As:

Achromycin; Topicycline; 4-Epitetracycline; Achromycin V; Hostacyclin; Sustamycin; Tetrabid; Tetracycline Hydrochloride; Tetracycline Monohydrochloride; 4 Epitetracycline; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-

Relationship Network

Drug Context: Research Results

Experts

1.	Geisser, Peter: 2 articles (01/2007 - 01/2007)
2.	Venter, Jan L: 2 articles (01/2007 - 01/2007)
3.	Venter, Cornea: 2 articles (01/2007 - 01/2007)
4.	Potgieter, Maria A: 2 articles (01/2007 - 01/2007)
5.	Lee, Hsi-Ming: 2 articles (05/2006 - 10/2005)
6.	Aimetti, M: 2 articles (01/2005 - 03/2004)
7.	Torta, I: 2 articles (01/2005 - 03/2004)
8.	Romano, F: 2 articles (01/2005 - 03/2004)
9.	Millet, Virginie: 2 articles (12/2002 - 07/2002)
10.	Apparailly, Florence: 2 articles (12/2002 - 07/2002)

Related Diseases

1.	Infection 05/01/2000 - "[Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]" 11/01/1998 - "The patient's infection was treated successfully with tetracycline. " 06/01/1989 - "Like the natural disease, infection in experimentally inoculated cats was progressive in nature, but could be treated successfully with tetracycline." 01/01/1991 - "To test the hypothesis that a longer treatment course might be more effective in preventing recurrent infection, the authors conducted a randomized trial that compared 7- and 21-day regimens of tetracycline administration. " 01/01/1996 - "Infection ranges from subclinical to fatal; tetracycline appears to be an effective therapy. " Order ALL the reference details at left...
2.	Acne Vulgaris 03/01/1990 - "This double-blind, parallel group multicentre study in 85 hospital out-patients with mild to moderate acne evaluated the efficacy of 2.2 mg/ml topical tetracycline or placebo applied twice daily for 16 weeks together with an initial course of oral tetracycline, at doses of 1000 mg/day during weeks 1-4 and 500 mg/day during weeks 5-8. Acne severity improved significantly (P less than 0.01) with both treatments after 8 and 16 weeks. " 06/01/1976 - "Oral tetracycline, 0.5 gm daily, was statistically significantly more effective for acne than placebo after 4, 7, 10, and 12 weeks of therapy. " 03/01/1976 - "Detailed statistical analysis indicates that the conclusion is valid that the tetracycline preparation is beneficial in the treatment of acne vulgaris. " 10/01/2008 - "CONCLUSION: Tetracycline is a well-tolerated topical agent and is particularly effective in the treatment of inflammatory lesions in acne." 01/15/1976 - "All tetracycline preparations seem to be systemically effective in acne. " Order ALL the reference details at left...
3.	Cholera 05/01/1987 - "However, patients with cholera who received 1200 mg of BS plus tetracycline did not have significant reduction in stool output compared with patients who received tetracycline alone. " 01/01/2009 - "Tetracycline, recommended by the WHO for treating cholera in adults, was effective against all the strains tested. " 03/01/2002 - "The results of the study indicate that tetracycline therapy is clinically useful in the treatment of severe cholera due to V. cholerae O139 Bengal." 09/01/1989 - "These data indicate that a single dose of 1 g of tetracycline is effective in the treatment of cholera, but it is asymptomatic bacteriologic relapse. " 08/01/1989 - "Tetracycline remains effective in cholera. " Order ALL the reference details at left...
4.	Periodontitis 05/01/1998 - "The safety profile, longer-term drug retention, antimicrobial activity, and clinical response in this Phase I study suggest that this tetracycline-containing copolymer gel platform may represent a safe and effective bioerodible therapy for periodontitis. " 01/01/1999 - "The purpose of this single-blind, randomized study was to evaluate the clinical efficacy of slow-release tetracycline fibers as an adjunct to initial periodontal therapy in moderate to advanced periodontitis patients who had no periodontal treatment before. " 04/01/1997 - "The purpose of this study was to evaluate the safety and clinical efficacy of controlled-release tetracycline-containing fibers in patients with refractory periodontitis versus the preceding classical treatment. " 01/01/2009 - "CONCLUSION: Tetracycline applied with a microbrush may be an alternative treatment for persistent periodontitis that can probably be mediated by reduction of microorganism proliferation" 01/01/2009 - "Local application of tetracycline solution with a microbrush: an alternative treatment for persistent periodontitis." Order ALL the reference details at left...
5.	Inflammation 05/01/1985 - "Intensive antimicrobial measures, including topical inorganic salt applications and systemic tetracycline, were helpful in limiting clinical inflammation and subgingival colonization by periodontopathogens during orthodontic therapy. " 07/01/2008 - "OBJECTIVE: A transgenic mouse model was generated that allows conditional expression of human PLTP, based on the tetracycline-responsive gene system, to study the effects of an acute increase in plasma PLTP activity as may occur in inflammation. " 01/01/2003 - "In our study tetracycline hydrochloride acted as an immunomodulator, which was able to reduce manifestations of inflammation response during TBE course; this action led to quicker improvement of symptoms and, consequently, to a faster clinical recovery. " 12/01/2007 - "The clinical use of tetracycline-type drugs in treatment of chronic airway inflammation is becoming a topic of intense interest. " 06/01/2001 - "CONCLUSION: The results are consistent with the hypothesis that tetracycline can decrease inflammation independent of a reduction in the bacterial load. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Doxycycline (Vibramycin)
2.	Minocycline (Cyclops)
3.	Erythromycin (Erycette)
4.	Metronidazole (Metric)
5.	Anti-Bacterial Agents (Antibiotics)
6.	Chloramphenicol (Chloromycetin)
7.	Amoxicillin (Wymox)
8.	Penicillins (Penicillin)
9.	Streptomycin (Streptomycin Sulfate)
10.	Niacinamide (Nicotinamide)

Related Therapies and Procedures

1.	Root Planing
2.	Sclerotherapy
3.	Pleurodesis
4.	Debridement
5.	Aftercare (After-Treatment)

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14726 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>